Recent advances in the development of tissue transglutaminase (TG2) inhibitors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the development of tissue transglutaminase (TG2) inhibitors
Authors
Keywords
Tissue transglutaminase, TG2, Inhibitors, Structure–activity relationships (SAR)
Journal
AMINO ACIDS
Volume 44, Issue 1, Pages 119-127
Publisher
Springer Nature
Online
2011-12-12
DOI
10.1007/s00726-011-1188-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dihydroisoxazole Analogs for Labeling and Visualization of Catalytically Active Transglutaminase 2
- (2011) Laila Dafik et al. CHEMISTRY & BIOLOGY
- Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease
- (2011) Robin Verhaar et al. NEUROCHEMISTRY INTERNATIONAL
- Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation
- (2011) Gozde Colak et al. PLoS One
- Potent transglutaminase inhibitors, dithio β-aminoethyl ketones
- (2010) Shoichiro Ozaki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2
- (2010) Cornelius Klöck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library
- (2010) Yoshiaki Sugimura et al. CYTOTECHNOLOGY
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
- (2009) Ellen M. Sletten et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Photolabeling of Tissue Transglutaminase Reveals the Binding Mode of Potent Cinnamoyl Inhibitors†
- (2009) Christophe Pardin et al. BIOCHEMISTRY
- Potent transglutaminase inhibitors, aryl β-aminoethyl ketones
- (2009) Shoichiro Ozaki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Increased TG2 Expression Can Result in Induction of Transforming Growth Factor β1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide
- (2009) Dilek Telci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transglutaminase inhibition ameliorates experimental diabetic nephropathy
- (2009) Linghong Huang et al. KIDNEY INTERNATIONAL
- Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library
- (2008) Kiyotaka Hitomi et al. AMINO ACIDS
- Synthesis of potent water-soluble tissue transglutaminase inhibitors
- (2008) Martin Griffin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits
- (2008) Masanobu Okauchi et al. BRAIN RESEARCH
- Reversible and Competitive Cinnamoyl Triazole Inhibitors of Tissue Transglutaminase
- (2008) Christophe Pardin et al. Chemical Biology & Drug Design
- Identification of Chemical Inhibitors to Human Tissue Transglutaminase by Screening Existing Drug Libraries
- (2008) Thung-S. Lai et al. CHEMISTRY & BIOLOGY
- Cinnamoyl Inhibitors of Tissue Transglutaminase†
- (2008) Christophe Pardin et al. JOURNAL OF ORGANIC CHEMISTRY
- Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
- (2008) Matthew Siegel et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started